哺乳动物CHO细胞重组抗体表达的研究进展
Research Progress on Recombinant Antibody Expression in Mammalian CHO Cells
摘要: 重组抗体药物在医药市场中的占比不断增大。哺乳动物细胞表达系统相比原核和真核表达系统能够高效表达重组抗体并进行近似人源蛋白的翻译后修饰，使重组抗体具有更好的活性及稳定性，因此被广泛用于重组抗体的生产，其中以中国仓鼠卵巢细胞(Chinese Hamster Ovary, CHO)用途最为广泛。基于原有的CHO细胞表达平台，抗体表达产量和质量并不一致。文章聚焦于载体设计、基因整合技术、糖基化修饰、筛选放大策略以及工艺优化等方面的进展并进行综述，旨在探究CHO细胞表达平台面临的目的基因靶向整合效率低、高产克隆筛选繁重、工业放大产物质量不可控等不足，为进一步促进CHO细胞表达系统的效率与一致性提供研究思路。
Abstract: The proportion of recombinant antibody drugs in the pharmaceutical market is constantly increasing. Compared with prokaryotic and eukaryotic expression systems, mammalian cell expression systems can efficiently express recombinant antibodies and perform post-translational modifications similar to human proteins, endowing recombinant antibodies with better activity and stability. Therefore, they are widely used in the production of recombinant antibodies, among which Chinese hamster ovary cells are the most widely used. Based on the existing CHO cell expression platform, the yield and quality of antibody expression are inconsistent. This article reviews the progress in vector design, gene integration technology, screening and scaling-up strategies, and process optimization, aiming to explore the shortcomings of the CHO cell expression platform, such as low targeting integration efficiency of target genes, heavy workload in screening high-yield clones, and uncontrollable product quality during industrial scaling-up, and to provide research ideas for further improving the efficiency and consistency of the CHO cell expression system.
文章引用：吴俊源, 刘煜. 哺乳动物CHO细胞重组抗体表达的研究进展[J]. 药物资讯, 2026, 15(3): 173-184. https://doi.org/10.12677/pi.2026.153020

参考文献

[1] Coulet, M., Kepp, O., Kroemer, G. and Basmaciogullari, S. (2022) Metabolic Profiling of CHO Cells during the Production of Biotherapeutics. Cells, 11, Article No. 1929. [Google Scholar] [CrossRef] [PubMed]
[2] Majumdar, S., Desai, R., Hans, A., Dandekar, P. and Jain, R. (2025) From Efficiency to Yield: Exploring Recent Advances in CHO Cell Line Development for Monoclonal Antibodies. Molecular Biotechnology, 67, 369-392. [Google Scholar] [CrossRef] [PubMed]
[3] Zeh, N., Schmidt, M., Schulz, P. and Fischer, S. (2024) The New Frontier in CHO Cell Line Development: From Random to Targeted Transgene Integration Technologies. Biotechnology Advances, 75, Article ID: 108402. [Google Scholar] [CrossRef] [PubMed]
[4] Xu, W., Lin, Y., Mi, C., Pang, J. and Wang, T. (2023) Progress in Fed-Batch Culture for Recombinant Protein Production in CHO Cells. Applied Microbiology and Biotechnology, 107, 1063-1075. [Google Scholar] [CrossRef] [PubMed]
[5] Tihanyi, B. and Nyitray, L. (2020) Recent Advances in CHO Cell Line Development for Recombinant Protein Production. Drug Discovery Today: Technologies, 38, 25-34. [Google Scholar] [CrossRef] [PubMed]
[6] Poulain, A., Mullick, A., Massie, B. and Durocher, Y. (2019) Reducing Recombinant Protein Expression during CHO Pool Selection Enhances Frequency of High-Producing Cells. Journal of Biotechnology, 296, 32-41. [Google Scholar] [CrossRef] [PubMed]
[7] Wang, T. and Guo, X. (2020) Expression Vector Cassette Engineering for Recombinant Therapeutic Production in Mammalian Cell Systems. Applied Microbiology and Biotechnology, 104, 5673-5688. [Google Scholar] [CrossRef] [PubMed]
[8] Brown, A.J., Sweeney, B., Mainwaring, D.O. and James, D.C. (2015) NF-κB, CRE and YY1 Elements Are Key Functional Regulators of CMV Promoter‐driven Transient Gene Expression in CHO Cells. Biotechnology Journal, 10, 1019-1028. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, D., Dai, W., Wu, J. and Wang, J. (2018) Improving Transcriptional Activity of Human Cytomegalovirus Major Immediate-Early Promoter by Mutating NF-κB Binding Sites. Protein Expression and Purification, 142, 16-24. [Google Scholar] [CrossRef] [PubMed]
[10] Zhao, C.P., Guo, X., Chen, S., Li, C., Yang, Y., Zhang, J., et al. (2017) Matrix Attachment Region Combinations Increase Transgene Expression in Transfected Chinese Hamster Ovary Cells. Scientific Reports, 7, Article No. 42805. [Google Scholar] [CrossRef] [PubMed]
[11] Marx, N., Dhiman, H., Schmieder, V., Freire, C.M., Nguyen, L.N., Klanert, G., et al. (2021) Enhanced Targeted DNA Methylation of the CMV and Endogenous Promoters with dCas9-DNMT3A3L Entails Distinct Subsequent Histone Modification Changes in CHO Cells. Metabolic Engineering, 66, 268-282. [Google Scholar] [CrossRef] [PubMed]
[12] Ebadat, S., Ahmadi, S., Ahmadi, M., Nematpour, F., Barkhordari, F., Mahdian, R., et al. (2017) Evaluating the Efficiency of CHEF and CMV Promoter with IRES and Furin/2A Linker Sequences for Monoclonal Antibody Expression in CHO Cells. PLoS ONE, 12, e0185967. [Google Scholar] [CrossRef] [PubMed]
[13] Mauro, V.P. and Chappell, S.A. (2018) Considerations in the Use of Codon Optimization for Recombinant Protein Expression. In: Hacker, D.L., Ed., Recombinant Protein Expression in Mammalian Cells, Springer, 275-288. [Google Scholar] [CrossRef] [PubMed]
[14] Newman, Z.R., Young, J.M., Ingolia, N.T. and Barton, G.M. (2016) Differences in Codon Bias and GC Content Contribute to the Balanced Expression of TLR7 and TLR9. Proceedings of the National Academy of Sciences, 113, E1362-E1371. [Google Scholar] [CrossRef] [PubMed]
[15] Zhou, M., Wang, T., Fu, J., Xiao, G. and Liu, Y. (2015) Nonoptimal Codon Usage Influences Protein Structure in Intrinsically Disordered Regions. Molecular Microbiology, 97, 974-987. [Google Scholar] [CrossRef] [PubMed]
[16] Fallahpour, A., Gureghian, V., Filion, G.J., Lindner, A.B. and Pandi, A. (2025) Codontransformer: A Multispecies Codon Optimizer Using Context-Aware Neural Networks. Nature Communications, 16, Article No. 3205. [Google Scholar] [CrossRef] [PubMed]
[17] Ramezani, A., Mahmoudi Maymand, E., Yazdanpanah-Samani, M., Hosseini, A., Toghraie, F.S. and Ghaderi, A. (2017) Improving Pertuzumab Production by Gene Optimization and Proper Signal Peptide Selection. Protein Expression and Purification, 135, 24-32. [Google Scholar] [CrossRef] [PubMed]
[18] Srila, W., Oli, D. and Yamabhai, M. (2024) Codon and Signal Peptide Optimization to Enhance Therapeutic Antibody Production from CHO Cells. In: Meleady, P., Ed., Heterologous Protein Production in CHO Cells, Springer US, 33-48. [Google Scholar] [CrossRef] [PubMed]
[19] Dangi, A.K., Sinha, R., Dwivedi, S., Gupta, S.K. and Shukla, P. (2018) Cell Line Techniques and Gene Editing Tools for Antibody Production: A Review. Frontiers in Pharmacology, 9, Article No. 630. [Google Scholar] [CrossRef] [PubMed]
[20] Hosur, V., Low, B.E. and Wiles, M.V. (2022) Programmable RNA-Guided Large DNA Transgenesis by CRISPR/Cas9 and Site-Specific Integrase Bxb1. Frontiers in Bioengineering and Biotechnology, 10, Article ID: 910151. [Google Scholar] [CrossRef] [PubMed]
[21] Pandey, S., Gao, X.D., Krasnow, N.A., McElroy, A., Tao, Y.A., Duby, J.E., et al. (2025) Efficient Site-Specific Integration of Large Genes in Mammalian Cells via Continuously Evolved Recombinases and Prime Editing. Nature Biomedical Engineering, 9, 22-39. [Google Scholar] [CrossRef] [PubMed]
[22] Zhang, C., Chang, F., Miao, H., Fu, Y., Tong, X., Feng, Y., et al. (2023) Construction and Application of a Multifunctional CHO Cell Platform Utilizing Cre/Lox and Dre/Rox Site-Specific Recombination Systems. Frontiers in Bioengineering and Biotechnology, 11, Article ID: 1320841. [Google Scholar] [CrossRef] [PubMed]
[23] Crawford, Y., Zhou, M., Hu, Z., Joly, J., Snedecor, B., Shen, A., et al. (2013) Fast Identification of Reliable Hosts for Targeted Cell Line Development from a Limited‐Genome Screening Using Combined φC31 integrase and CRE-Lox Technologies. Biotechnology Progress, 29, 1307-1315. [Google Scholar] [CrossRef] [PubMed]
[24] Ghanbari, S., Bayat, E., Azizi, M., Fard-Esfahani, P., Modarressi, M.H. and Davami, F. (2022) Targeted Integration in CHO Cells Using CRIS-PITCh/Bxb1 Recombinase-Mediated Cassette Exchange Hybrid System. Applied Microbiology and Biotechnology, 107, 769-783. [Google Scholar] [CrossRef] [PubMed]
[25] Gupta, S.K. and Shukla, P. (2017) Gene Editing for Cell Engineering: Trends and Applications. Critical Reviews in Biotechnology, 37, 672-684. [Google Scholar] [CrossRef] [PubMed]
[26] Zhao, M., Wang, J., Luo, M., Luo, H., Zhao, M., Han, L., et al. (2018) Rapid Development of Stable Transgene CHO Cell Lines by CRISPR/Cas9-Mediated Site-Specific Integration into C12orf35. Applied Microbiology and Biotechnology, 102, 6105-6117. [Google Scholar] [CrossRef] [PubMed]
[27] Min, H., Kim, S.M., Kim, D., Lee, S., Lee, S. and Lee, J.S. (2022) Hybrid Cell Line Development System Utilizing Site-Specific Integration and Methotrexate-Mediated Gene Amplification in Chinese Hamster Ovary Cells. Frontiers in Bioengineering and Biotechnology, 10, Article ID: 977193. [Google Scholar] [CrossRef] [PubMed]
[28] Cao, X., Yuan, J., Bai, Z., Zhang, M., Yun, Y., Wang, X., et al. (2025) Effect of CHO Cell Line Constructed with CMAH Gene-Directed Integration on the Recombinant Protein Expression. International Journal of Biological Macromolecules, 292, Article ID: 139274. [Google Scholar] [CrossRef] [PubMed]
[29] Tejwani, V., Andersen, M.R., Nam, J.H. and Sharfstein, S.T. (2018) Glycoengineering in CHO Cells: Advances in Systems Biology. Biotechnology Journal, 13, e1700234. [Google Scholar] [CrossRef] [PubMed]
[30] Heffner, K.M., Wang, Q., Hizal, D.B., Can, Ö. and Betenbaugh, M.J. (2021) Glycoengineering of Mammalian Expression Systems on a Cellular Level. In: Rapp, E. and Reichl, U., Eds., Advances in Glycobiotechnology, Springer International Publishing, 37-69. [Google Scholar] [CrossRef] [PubMed]
[31] Shivatare, S.S., Shivatare, V.S. and Wong, C. (2022) Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments. Chemical Reviews, 122, 15603-15671. [Google Scholar] [CrossRef] [PubMed]
[32] Wong, A.W., Baginski, T.K. and Reilly, D.E. (2010) Enhancement of DNA Uptake in FUT8‐Deleted CHO Cells for Transient Production of Afucosylated Antibodies. Biotechnology and Bioengineering, 106, 751-763. [Google Scholar] [CrossRef] [PubMed]
[33] Moore, D.C., Elmes, J.B., Shibu, P.A., Larck, C. and Park, S.I. (2020) Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas. Annals of Pharmacotherapy, 54, 371-379. [Google Scholar] [CrossRef] [PubMed]
[34] Lin, N., Mascarenhas, J., Sealover, N.R., George, H.J., Brooks, J., Kayser, K.J., et al. (2015) Chinese Hamster Ovary (CHO) Host Cell Engineering to Increase Sialylation of Recombinant Therapeutic Proteins by Modulating Sialyltransferase Expression. Biotechnology Progress, 31, 334-346. [Google Scholar] [CrossRef] [PubMed]
[35] Onitsuka, M., Kim, W., Ozaki, H., Kawaguchi, A., Honda, K., Kajiura, H., et al. (2012) Enhancement of Sialylation on Humanized IgG-Like Bispecific Antibody by Overexpression of α2,6-Sialyltransferase Derived from Chinese Hamster Ovary Cells. Applied Microbiology and Biotechnology, 94, 69-80. [Google Scholar] [CrossRef] [PubMed]
[36] Heinzelmann, D., Michelarakis, N., Reuss, F., Lindner, B., Karow‐Zwick, A.R., Bauer, J., et al. (2025) Bacterial Glutamine Synthetases as a Novel Metabolic Selection Marker to Improve CHO Cell Culture Performance through Selection Stringency Modulation. Biotechnology Journal, 20, e70119. [Google Scholar] [CrossRef] 
[37] Srila, W., Baumann, M., Riedl, M., Rangnoi, K., Borth, N. and Yamabhai, M. (2023) Glutamine Synthetase (GS) Knockout (KO) Using CRISPR/Cpf1 Diversely Enhances Selection Efficiency of CHO Cells Expressing Therapeutic Antibodies. Scientific Reports, 13, Article No. 10473. [Google Scholar] [CrossRef] [PubMed]
[38] Chusainow, J., Yang, Y.S., Yeo, J.H.M., Toh, P.C., Asvadi, P., Wong, N.S.C., et al. (2009) A Study of Monoclonal Antibody‐Producing CHO Cell Lines: What Makes a Stable High Producer? Biotechnology and Bioengineering, 102, 1182-1196. [Google Scholar] [CrossRef] [PubMed]
[39] Lee, J.H., Park, J.H., Park, S.H., Kim, S., Kim, J.Y., Min, J., et al. (2018) Co-Amplification of EBNA-1 and PyLT through Dhfr-Mediated Gene Amplification for Improving Foreign Protein Production in Transient Gene Expression in CHO Cells. Applied Microbiology and Biotechnology, 102, 4729-4739. [Google Scholar] [CrossRef] [PubMed]
[40] Lin, P., Chan, K.F., Kiess, I.A., Tan, J., Shahreel, W., Wong, S., et al. (2019) Attenuated Glutamine Synthetase as a Selection Marker in CHO Cells to Efficiently Isolate Highly Productive Stable Cells for the Production of Antibodies and Other Biologics. mAbs, 11, 965-976. [Google Scholar] [CrossRef] [PubMed]
[41] Fan, L., Kadura, I., Krebs, L.E., Hatfield, C.C., Shaw, M.M. and Frye, C.C. (2012) Improving the Efficiency of CHO Cell Line Generation Using Glutamine Synthetase Gene Knockout Cells. Biotechnology and Bioengineering, 109, 1007-1015. [Google Scholar] [CrossRef] [PubMed]
[42] Noh, S.M., Shin, S. and Lee, G.M. (2018) Comprehensive Characterization of Glutamine Synthetase-Mediated Selection for the Establishment of Recombinant CHO Cells Producing Monoclonal Antibodies. Scientific Reports, 8, Article No. 5361. [Google Scholar] [CrossRef] [PubMed]
[43] Tejwani, V., Chaudhari, M., Rai, T. and Sharfstein, S.T. (2021) High‐Throughput and Automation Advances for Accelerating Single‐Cell Cloning, Monoclonality and Early Phase Clone Screening Steps in Mammalian Cell Line Development for Biologics Production. Biotechnology Progress, 37, e3208. [Google Scholar] [CrossRef] [PubMed]
[44] Lindgren, K., Salmén, A., Lundgren, M., Bylund, L., Ebler, Å., Fäldt, E., et al. (2009) Automation of Cell Line Development. Cytotechnology, 59, 1-10. [Google Scholar] [CrossRef] [PubMed]
[45] Fieder, J., Schulz, P., Gorr, I., Bradl, H. and Wenger, T. (2017) A Single‐Step FACS Sorting Strategy in Conjunction with Fluorescent Vital Dye Imaging Efficiently Assures Clonality of Biopharmaceutical Production Cell Lines. Biotechnology Journal, 12, Article ID: 1700002. [Google Scholar] [CrossRef] [PubMed]
[46] Zhang, Y. (2009) Approaches to Optimizing Animal Cell Culture Process: Substrate Metabolism Regulation and Protein Expression Improvement. In: Zhong, J.-J., et al., Eds., Biotechnology in China I, Springer, 177-215. [Google Scholar] [CrossRef] [PubMed]
[47] Fan, Y., Jimenez Del Val, I., Müller, C., Wagtberg Sen, J., Rasmussen, S.K., Kontoravdi, C., et al. (2015) Amino Acid and Glucose Metabolism in Fed‐Batch CHO Cell Culture Affects Antibody Production and Glycosylation. Biotechnology and Bioengineering, 112, 521-535. [Google Scholar] [CrossRef] [PubMed]
[48] Kuwae, S., Miyakawa, I. and Doi, T. (2018) Development of a Chemically Defined Platform Fed-Batch Culture Media for Monoclonal Antibody-Producing CHO Cell Lines with Optimized Choline Content. Cytotechnology, 70, 939-948. [Google Scholar] [CrossRef] [PubMed]
[49] Pan, X., Streefland, M., Dalm, C., Wijffels, R.H. and Martens, D.E. (2017) Selection of Chemically Defined Media for CHO Cell Fed-Batch Culture Processes. Cytotechnology, 69, 39-56. [Google Scholar] [CrossRef] [PubMed]
[50] Li, W., Fan, Z., Lin, Y. and Wang, T. (2021) Serum-Free Medium for Recombinant Protein Expression in Chinese Hamster Ovary Cells. Frontiers in Bioengineering and Biotechnology, 9, Article ID: 646363. [Google Scholar] [CrossRef] [PubMed]
[51] Burky, J.E., Wesson, M.C., Young, A., Farnsworth, S., Dionne, B., Zhu, Y., et al. (2007) Protein‐Free Fed‐Batch Culture of Non-GS NS0 Cell Lines for Production of Recombinant Antibodies. Biotechnology and Bioengineering, 96, 281-293. [Google Scholar] [CrossRef] [PubMed]
[52] Xiao, Z., Sabourin, M., Piras, G. and Gorfien, S.F. (2014) Screening and Optimization of Chemically Defined Media and Feeds with Integrated and Statistical Approaches. In: Pörtner, R., Ed., Animal Cell Biotechnology: Methods and Protocols, Humana Press, 117-135. [Google Scholar] [CrossRef] [PubMed]
[53] Zhu, Z., Chen, X., Li, W., Zhuang, Y., Zhao, Y. and Wang, G. (2023) Understanding the Effect of Temperature Downshift on CHO Cell Growth, Antibody Titer and Product Quality by Intracellular Metabolite Profiling and in Vivo Monitoring of Redox State. Biotechnology Progress, 39, e3352. [Google Scholar] [CrossRef] [PubMed]
[54] Yang, W.C., Minkler, D.F., Kshirsagar, R., Ryll, T. and Huang, Y.-M. (2016) Concentrated Fed-Batch Cell Culture Increases Manufacturing Capacity without Additional Volumetric Capacity. Journal of Biotechnology, 217, 1-11. [Google Scholar] [CrossRef] [PubMed]
[55] Mason, M., Sweeney, B., Cain, K., Stephens, P. and Sharfstein, S. (2014) Reduced Culture Temperature Differentially Affects Expression and Biophysical Properties of Monoclonal Antibody Variants. Antibodies, 3, 253-271. [Google Scholar] [CrossRef] [PubMed]
[56] Mellahi, K., Brochu, D., Gilbert, M., Perrier, M., Ansorge, S., Durocher, Y., et al. (2019) Assessment of Fed-Batch Cultivation Strategies for an Inducible CHO Cell Line. Journal of Biotechnology, 298, 45-56. [Google Scholar] [CrossRef] [PubMed]
[57] Paul, K., Böttinger, K., Mitic, B.M., Scherfler, G., Posch, C., Behrens, D., et al. (2020) Development, Characterization, and Application of a 2‐Compartment System to Investigate the Impact of pH Inhomogeneities in Large‐Scale CHO‐Based Processes. Engineering in Life Sciences, 20, 368-378. [Google Scholar] [CrossRef] [PubMed]
[58] Limberg, M.H., Joachim, M., Klein, B., Wiechert, W. and Oldiges, M. (2017) pH Fluctuations Imperil the Robustness of C. glutamicum to Short Term Oxygen Limitation. Journal of Biotechnology, 259, 248-260. [Google Scholar] [CrossRef] [PubMed]
[59] Jiang, R., Chen, H. and Xu, S. (2018) pH Excursions Impact CHO Cell Culture Performance and Antibody N-Linked Glycosylation. Bioprocess and Biosystems Engineering, 41, 1731-1741. [Google Scholar] [CrossRef] [PubMed]
[60] Reddy, J.V., Singh, S.K., Leibiger, T., Lee, K.H., Ierapetritou, M. and Papoutsakis, E.T. (2025) Flux Balance Analysis and Peptide Mapping Elucidate the Impact of Bioreactor pH on Chinese Hamster Ovary (CHO) Cell Metabolism and N-Linked Glycosylation in the Fab and Fc Regions of the Produced IgG. Metabolic Engineering, 87, 37-48. [Google Scholar] [CrossRef] [PubMed]
[61] MacDonald, M.A., Nöbel, M., Roche Recinos, D., Martínez, V.S., Schulz, B.L., Howard, C.B., et al. (2022) Perfusion Culture of Chinese Hamster Ovary Cells for Bioprocessing Applications. Critical Reviews in Biotechnology, 42, 1099-1115. [Google Scholar] [CrossRef] [PubMed]
[62] Gomez, N., Barkhordarian, H., Lull, J., Huh, J., GhattyVenkataKrishna, P. and Zhang, X. (2019) Perfusion CHO Cell Culture Applied to Lower Aggregation and Increase Volumetric Productivity for a Bispecific Recombinant Protein. Journal of Biotechnology, 304, 70-77. [Google Scholar] [CrossRef] [PubMed]
[63] Rish, A.J., Drennen, J.K. and Anderson, C.A. (2022) Metabolic Trends of Chinese Hamster Ovary Cells in Biopharmaceutical Production under Batch and Fed-Batch Conditions. Biotechnology Progress, 38, e3220. [Google Scholar] [CrossRef] [PubMed]
[64] Nöbel, M., Barry, C., MacDonald, M.A., Baker, K., Shave, E., Mahler, S., et al. (2024) Harnessing Metabolic Plasticity in CHO Cells for Enhanced Perfusion Cultivation. Biotechnology and Bioengineering, 121, 1370-1382. [Google Scholar] [CrossRef] [PubMed]